Form 4 holding
EVP, Head of R&D
Jasper Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 3,150
- Estimated value
- $2,760
- Report date
- 16 Jul 2026
- Price
- $0.8762
- Ownership
- By 2019 WMML Revocable Trust